Filtros de búsqueda

Lista de obras de

Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting

artículo científico publicado en 2019

Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System

artículo científico publicado en 2018

Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting

scientific article published on 03 February 2020

Comparisons of diabetic retinopathy events associated with glucose-lowering drugs in patients with type 2 diabetes mellitus: a network meta-analysis

artículo científico publicado en 2018

Development and validation of an algorithm to identify drug-induced anaphylaxis in the Beijing Pharmacovigilance Database.

artículo científico publicado en 2018

Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials

scientific article published on 21 May 2019

Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults

scientific article published on 30 August 2019

Drug-induced anaphylaxis in China: a 10 year retrospective analysis of the Beijing Pharmacovigilance Database.

artículo científico publicado en 2017

Incretin-Based Therapies and Diabetic Retinopathy: Real-World Evidence in Older U.S. Adults

artículo científico publicado en 2018

Real-world evidence on sodium-glucose cotransporter-2 inhibitor use and risk of Fournier's gangrene

artículo científico publicado en 2020

SGLT2 inhibitor plus DPP-4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta-analysis.

artículo científico publicado en 2018

Sodium-glucose co-transporter-2 inhibitor use and risk of lower-extremity amputation: Evolving questions, evolving answers

artículo científico publicado en 2019

Traditional Chinese medicine and drug-induced anaphylaxis: data from the Beijing pharmacovigilance database

scientific article published on 26 July 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda